ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 77 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,263 | -17.4% | 23,243 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $188,079 | +75.8% | 22,417 | -7.0% | 0.00% | 0.0% |
| Q1 2022 | $107,000 | +3.9% | 24,096 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $103,000 | -55.8% | 25,792 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $233,000 | -24.4% | 26,563 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $308,000 | +805.9% | 27,195 | +100.3% | 0.00% | – |
| Q1 2020 | $34,000 | -59.0% | 13,576 | -5.5% | 0.00% | – |
| Q4 2019 | $83,000 | +10.7% | 14,360 | +0.8% | 0.00% | – |
| Q3 2019 | $75,000 | -12.8% | 14,242 | -0.7% | 0.00% | – |
| Q2 2019 | $86,000 | -29.5% | 14,340 | +6.4% | 0.00% | – |
| Q1 2019 | $122,000 | +6.1% | 13,472 | -3.1% | 0.00% | – |
| Q4 2018 | $115,000 | -25.8% | 13,909 | +23.4% | 0.00% | -100.0% |
| Q3 2018 | $155,000 | +89.0% | 11,268 | +8.6% | 0.00% | – |
| Q2 2018 | $82,000 | – | 10,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 484,096 | $6,317,000 | 5.34% |
| CVI Holdings, LLC | 200,000 | $2,760,000 | 4.56% |
| Mesirow Financial Investment Management, Inc. | 38,097 | $526,000 | 2.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,142,089 | $15,761,000 | 1.81% |
| 683 Capital Management, LLC | 1,350,000 | $18,630,000 | 1.21% |
| Stonepine Capital Management, LLC | 145,000 | $2,001,000 | 1.17% |
| Perceptive Advisors | 3,085,458 | $42,579,000 | 1.14% |
| EAM Investors, LLC | 312,092 | $4,307,000 | 0.64% |
| MANGROVE PARTNERS IM, LLC | 707,746 | $9,767,000 | 0.62% |
| EAM Global Investors LLC | 86,614 | $1,195,000 | 0.48% |